Search
Legend Biotech Corp
LEGNAdd to Watchlist
18.550USD
-0.500-2.62%
Close 07-31 16:00（ET）Quotes delayed by 15 min
3.59BMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-31The current earnings forecast score of Legend Biotech Corp is 8.24, ranking 153 out of 385 in the Biotechnology & Medical Research industry. The average price target is 74.00, with a high of 91.00 and a low of 48.00.
Analyst Rating
Based on
17
analysts
Buy
Current Rating
55.781
Target Price
+195.92%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
496
Total
6
Median
7
Average
Company name
Ratings
Analysts
Legend Biotech Corp
LEGN
17
Beigene Ltd
ONC
28
argenx SE
ARGX
26
Ionis Pharmaceuticals Inc
IONS
26
IQVIA Holdings Inc
IQV
25
Insmed Inc
INSM
23
1
2
3
...
99
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Legend Biotech Corp's expected revenue for the next quarter?
Legend Biotech Corp's expected revenue is 355.77M.
What is Legend Biotech Corp's price target?
Analysts forecast that Legend Biotech Corp's price target is USD 74.00, with the highest forecast at USD 91.00 and the lowest forecast at USD 48.00.
How have Legend Biotech CorpLEGN's recent earnings per share performed?
The market expectation was USD -0.29, while Legend Biotech CorpLEGN's earnings per share (EPS) for the previous quarter was USD -0.17. EPS for the next quarter is expected at USD 0.07.
What is the analyst rating for Legend Biotech Corp?
Based on the ratings of Legend Biotech Corp's stock from 17 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.